Research programme: PET imaging agents - FluoroPharma

Drug Profile

Research programme: PET imaging agents - FluoroPharma

Alternative Names: [18F]AppCHFppA; AZPET; VasoPET

Latest Information Update: 20 Mar 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Harvard Medical School; Massachusetts General Hospital
  • Developer FluoroPharma
  • Class Deoxy sugars; Imaging agents; Purines
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Atherosclerosis; Coronary disorders
  • Research Alzheimer's disease

Most Recent Events

  • 20 Mar 2012 Early research in Alzheimer's disease (diagnosis) in USA (Parenteral)
  • 29 Jan 2009 Preclinical development is ongoing in the US
  • 05 Mar 2008 Preclinical trials in Coronary disorders (diagnosis) in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top